Morgan Stanley

Rather than whirling in an impeccable rotation, Perfect World (NASDAQ: PWRD) gaming developer missed the mark with its first quarter revenue. Based in People's Republic of China, PWRD brought in profits of $114.1 million, falling $2 million below Street estimates. With management guiding the...

Mary Meeker, head of Morgan Stanley's technology research unit, is out with a new report on the growth of mobile technology. Titled internet trends, she divides the presentation into five parts: basic stats, re-imagination, the economy and how it affects tech trends, "USA Inc," and are new internet...

In a report published earlier today, Morgan Stanley reiterated its Overweight rating for Perfect World Co., Ltd. (NASDAQ: PWRD), but lowered its price target from $18.40 to $16.70. Morgan Stanley went on to say “Despite a softer 2Q outlook, we believe Perfect World offers deep value, as it trades...

Morgan Stanley reiterates its Overweight rating on Madison Square Garden (NASDAQ: MSG) and increases its price target from $36 to $43. Morgan Stanley notes, "Above consensus on affiliate revenue growth at MSG, and our estimates appear conservative: We are raising our FY13 Media rev forecast by...

Morgan Stanley has published a research report on Vertex Pharmaceuticals (NASDAQ: VRTX) and has lowered the price target from $51 to $46 based on corrected interim CF data that came in weaker than expected. In the report, Morgan Stanley writes, "We are lowering our VRTX PT to $46 on worse CF data...

Morgan Stanley has opened a research tactical idea on Focus Media (NASDAQ: FMCN) staying that the share price is expected to rise over the next 30 days. In the report, Morgan Stanley writes, "This is because the stock has traded off recently, making short term valuation much more compelling. We...

According to a research report this morning, Morgan Stanley reports revenues to be 3.3% higher than expected and revenue for Sanderson Farms (NASDAQ: SAFM) to be right in-line with estimate of 9/9%. Morgan Stanley explained, “We believe that F12 chicken prices are currently at peak levels, and...

According to a research report published this morning, Morgan Stanley has lowered Teva Pharmaceuticals' (NASDAQ: TEVA) PT from $47 to $44. In the report, Morgan Stanley mentioned, "We are lowering our 2012E-‘15E revenue by 5% and EPS by 3% and also reducing our PT from $47 to $44 following...

According to a research report published this morning, Morgan Stanley has increased The Walt Disney Company's (NYSE: DIS) PT from $46 to $51. In the report, Morgan Stanley said, "We are raising our base case/PT and bull case to $51 and $57, respectively. Estimates rise on higher margins at ABC and...

According to a research report published this morning, Morgan Stanley has increased eBay's (NASDAQ: EBAY) PT from $45 to $49. In the report, Morgan Stanley said, "The long-term winners in eCommerce will likely be those that can leverage both a high-traffic destination site with a global...